EMC's business objective is to develop and to provide novel products, strategies, and tools for the drug discovery process by

• Organic and combinatorial chemistry
  Custom synthesis of highly diverse and target-oriented compound collections
  
• Lead optimisation
  Focused compound collections and structure elucidation of metabolites, scale up synthesis
  
• Peptide and protein chemistry
  Peptide collections and peptide analogues for assay development, target validation, proteomics, and peptide therapeutics
  
• Biochemicals from stock
  Immunmodulators, tools for TLR research, chemically defined adjuvants, bioactive peptides, anti-infectives, siderophores, DPP-4- and HDAC-inhibitors